
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Recent advances in alcohol-related liver disease (ALD): summary of a Gut round table meeting
Matías A. Ávila, Jean‐François Dufour, Alexander L. Gerbes, et al.
Gut (2019) Vol. 69, Iss. 4, pp. 764-780
Open Access | Times Cited: 158
Matías A. Ávila, Jean‐François Dufour, Alexander L. Gerbes, et al.
Gut (2019) Vol. 69, Iss. 4, pp. 764-780
Open Access | Times Cited: 158
Showing 1-25 of 158 citing articles:
Global burden of liver disease: 2023 update
Harshad Devarbhavi, Sumeet K. Asrani, Juan Pablo Arab, et al.
Journal of Hepatology (2023) Vol. 79, Iss. 2, pp. 516-537
Open Access | Times Cited: 806
Harshad Devarbhavi, Sumeet K. Asrani, Juan Pablo Arab, et al.
Journal of Hepatology (2023) Vol. 79, Iss. 2, pp. 516-537
Open Access | Times Cited: 806
Advanced glycation end products (AGEs) and other adducts in aging-related diseases and alcohol-mediated tissue injury
Wiramon Rungratanawanich, Ying Qu, Xin Wang, et al.
Experimental & Molecular Medicine (2021) Vol. 53, Iss. 2, pp. 168-188
Open Access | Times Cited: 242
Wiramon Rungratanawanich, Ying Qu, Xin Wang, et al.
Experimental & Molecular Medicine (2021) Vol. 53, Iss. 2, pp. 168-188
Open Access | Times Cited: 242
Intestinal Fungal Dysbiosis and Systemic Immune Response to Fungi in Patients With Alcoholic Hepatitis
Sonja Lang, Yi Duan, Jinyuan Liu, et al.
Hepatology (2019) Vol. 71, Iss. 2, pp. 522-538
Open Access | Times Cited: 184
Sonja Lang, Yi Duan, Jinyuan Liu, et al.
Hepatology (2019) Vol. 71, Iss. 2, pp. 522-538
Open Access | Times Cited: 184
Immunological mechanisms and therapeutic targets of fatty liver diseases
Hua Wang, Wajahat Z. Mehal, Laura E. Nagy, et al.
Cellular and Molecular Immunology (2020) Vol. 18, Iss. 1, pp. 73-91
Open Access | Times Cited: 152
Hua Wang, Wajahat Z. Mehal, Laura E. Nagy, et al.
Cellular and Molecular Immunology (2020) Vol. 18, Iss. 1, pp. 73-91
Open Access | Times Cited: 152
The Role of Gut-Derived Lipopolysaccharides and the Intestinal Barrier in Fatty Liver Diseases
Lingxuan An, Ulrich Wirth, Dominik Koch, et al.
Journal of Gastrointestinal Surgery (2021) Vol. 26, Iss. 3, pp. 671-683
Open Access | Times Cited: 125
Lingxuan An, Ulrich Wirth, Dominik Koch, et al.
Journal of Gastrointestinal Surgery (2021) Vol. 26, Iss. 3, pp. 671-683
Open Access | Times Cited: 125
Alcohol-associated liver disease
Bryan Mackowiak, Yaojie Fu, Luca Maccioni, et al.
Journal of Clinical Investigation (2024) Vol. 134, Iss. 3
Open Access | Times Cited: 101
Bryan Mackowiak, Yaojie Fu, Luca Maccioni, et al.
Journal of Clinical Investigation (2024) Vol. 134, Iss. 3
Open Access | Times Cited: 101
In vivo liver function reserve assessments in alcoholic liver disease by scalable photoacoustic imaging
Tong Sun, Jing Lv, Xingyang Zhao, et al.
Photoacoustics (2023) Vol. 34, pp. 100569-100569
Open Access | Times Cited: 58
Tong Sun, Jing Lv, Xingyang Zhao, et al.
Photoacoustics (2023) Vol. 34, pp. 100569-100569
Open Access | Times Cited: 58
Spatiotemporal Metabolic Liver Zonation and Consequences on Pathophysiology
Tomaž Martini, Félix Naef, Jan S. Tchorz
Annual Review of Pathology Mechanisms of Disease (2023) Vol. 18, Iss. 1, pp. 439-466
Closed Access | Times Cited: 44
Tomaž Martini, Félix Naef, Jan S. Tchorz
Annual Review of Pathology Mechanisms of Disease (2023) Vol. 18, Iss. 1, pp. 439-466
Closed Access | Times Cited: 44
Liver diseases and hepatocellular carcinoma in the Asia-Pacific region: burden, trends, challenges and future directions
Lung‐Yi Mak, Ken Liu, Sakkarin Chirapongsathorn, et al.
Nature Reviews Gastroenterology & Hepatology (2024) Vol. 21, Iss. 12, pp. 834-851
Closed Access | Times Cited: 23
Lung‐Yi Mak, Ken Liu, Sakkarin Chirapongsathorn, et al.
Nature Reviews Gastroenterology & Hepatology (2024) Vol. 21, Iss. 12, pp. 834-851
Closed Access | Times Cited: 23
Epigenetics in hepatocellular carcinoma development and therapy: The tip of the iceberg
Maite G. Fernández‐Barrena, María Arechederra, Leticia Colyn, et al.
JHEP Reports (2020) Vol. 2, Iss. 6, pp. 100167-100167
Open Access | Times Cited: 90
Maite G. Fernández‐Barrena, María Arechederra, Leticia Colyn, et al.
JHEP Reports (2020) Vol. 2, Iss. 6, pp. 100167-100167
Open Access | Times Cited: 90
Liver organoid as a 3D in vitro model for drug validation and toxicity assessment
Anastasia Brooks, Xiaowen Liang, Yonglong Zhang, et al.
Pharmacological Research (2021) Vol. 169, pp. 105608-105608
Closed Access | Times Cited: 69
Anastasia Brooks, Xiaowen Liang, Yonglong Zhang, et al.
Pharmacological Research (2021) Vol. 169, pp. 105608-105608
Closed Access | Times Cited: 69
Harnessing reactive oxygen/nitrogen species and inflammation: Nanodrugs for liver injury
Min Liu, Qiong Huang, Yan Zhu, et al.
Materials Today Bio (2022) Vol. 13, pp. 100215-100215
Open Access | Times Cited: 55
Min Liu, Qiong Huang, Yan Zhu, et al.
Materials Today Bio (2022) Vol. 13, pp. 100215-100215
Open Access | Times Cited: 55
Distinct histopathological phenotypes of severe alcoholic hepatitis suggest different mechanisms driving liver injury and failure
Jing Ma, Adrien Guillot, Zhihong Yang, et al.
Journal of Clinical Investigation (2022) Vol. 132, Iss. 14
Open Access | Times Cited: 49
Jing Ma, Adrien Guillot, Zhihong Yang, et al.
Journal of Clinical Investigation (2022) Vol. 132, Iss. 14
Open Access | Times Cited: 49
Alcohol-Associated Tissue Injury: Current Views on Pathophysiological Mechanisms
Liz Simon, Flavia M. Souza‐Smith, Patricia E. Molina
Annual Review of Physiology (2022) Vol. 84, Iss. 1, pp. 87-112
Open Access | Times Cited: 47
Liz Simon, Flavia M. Souza‐Smith, Patricia E. Molina
Annual Review of Physiology (2022) Vol. 84, Iss. 1, pp. 87-112
Open Access | Times Cited: 47
Nuclear Receptor PPARα as a Therapeutic Target in Diseases Associated with Lipid Metabolism Disorders
Ping Hu, Kaiqi Li, Xiaoxu Peng, et al.
Nutrients (2023) Vol. 15, Iss. 22, pp. 4772-4772
Open Access | Times Cited: 26
Ping Hu, Kaiqi Li, Xiaoxu Peng, et al.
Nutrients (2023) Vol. 15, Iss. 22, pp. 4772-4772
Open Access | Times Cited: 26
Sphingolipids Are Depleted in Alcohol-Related Liver Fibrosis
Maja Thiele, Tommi Suvitaival, Kajetan Trošt, et al.
Gastroenterology (2023) Vol. 164, Iss. 7, pp. 1248-1260
Open Access | Times Cited: 25
Maja Thiele, Tommi Suvitaival, Kajetan Trošt, et al.
Gastroenterology (2023) Vol. 164, Iss. 7, pp. 1248-1260
Open Access | Times Cited: 25
Gut Microbiota and Bacterial Translocation in the Pathogenesis of Liver Fibrosis
Roman Maslennikov, Elena Poluektova, O. Yu. Zolnikova, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 22, pp. 16502-16502
Open Access | Times Cited: 24
Roman Maslennikov, Elena Poluektova, O. Yu. Zolnikova, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 22, pp. 16502-16502
Open Access | Times Cited: 24
NLRP3: a new therapeutic target in alcoholic liver disease
Subhashini Brahadeeswaran, Tiasha Dasgupta, Venkatraman Manickam, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 23
Subhashini Brahadeeswaran, Tiasha Dasgupta, Venkatraman Manickam, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 23
Alcohol-associated liver disease—Global epidemiology
Fredrik Åberg, Z. Gordon Jiang, Helena Cortez‐Pinto, et al.
Hepatology (2024) Vol. 80, Iss. 6, pp. 1307-1322
Closed Access | Times Cited: 13
Fredrik Åberg, Z. Gordon Jiang, Helena Cortez‐Pinto, et al.
Hepatology (2024) Vol. 80, Iss. 6, pp. 1307-1322
Closed Access | Times Cited: 13
Alcohol-associated liver cancer
Yaojie Fu, Luca Maccioni, Xin Wei Wang, et al.
Hepatology (2024) Vol. 80, Iss. 6, pp. 1462-1479
Closed Access | Times Cited: 9
Yaojie Fu, Luca Maccioni, Xin Wei Wang, et al.
Hepatology (2024) Vol. 80, Iss. 6, pp. 1462-1479
Closed Access | Times Cited: 9
Inflammation in Alcohol-Associated Hepatitis: Pathogenesis and Therapeutic Targets
Dechun Feng, Seonghwan Hwang, Adrien Guillot, et al.
Cellular and Molecular Gastroenterology and Hepatology (2024) Vol. 18, Iss. 3, pp. 101352-101352
Open Access | Times Cited: 8
Dechun Feng, Seonghwan Hwang, Adrien Guillot, et al.
Cellular and Molecular Gastroenterology and Hepatology (2024) Vol. 18, Iss. 3, pp. 101352-101352
Open Access | Times Cited: 8
Chronic stress and corticosterone exacerbate alcohol-induced tissue injury in the gut-liver-brain axis
Pradeep K. Shukla, Avtar S. Meena, Kesha Dalal, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 51
Pradeep K. Shukla, Avtar S. Meena, Kesha Dalal, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 51
Aging exaggerates acute‐on‐chronic alcohol‐induced liver injury in mice and humans by inhibiting neutrophilic sirtuin 1‐C/EBPα‐miRNA‐223 axis
Ruixue Ren, Yong He, Dong Ding, et al.
Hepatology (2021) Vol. 75, Iss. 3, pp. 646-660
Open Access | Times Cited: 51
Ruixue Ren, Yong He, Dong Ding, et al.
Hepatology (2021) Vol. 75, Iss. 3, pp. 646-660
Open Access | Times Cited: 51
Aryl Hydrocarbon Receptor Deficiency in Intestinal Epithelial Cells Aggravates Alcohol-Related Liver Disease
Minyi Qian, Jun Liu, Danyang Zhao, et al.
Cellular and Molecular Gastroenterology and Hepatology (2021) Vol. 13, Iss. 1, pp. 233-256
Open Access | Times Cited: 45
Minyi Qian, Jun Liu, Danyang Zhao, et al.
Cellular and Molecular Gastroenterology and Hepatology (2021) Vol. 13, Iss. 1, pp. 233-256
Open Access | Times Cited: 45
Curcumol Suppresses CCF-Mediated Hepatocyte Senescence Through Blocking LC3B–Lamin B1 Interaction in Alcoholic Fatty Liver Disease
Xiaoyu Qi, Shuguo Zheng, Mingyue Ma, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 35
Xiaoyu Qi, Shuguo Zheng, Mingyue Ma, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 35